Literature DB >> 18502629

Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends.

Sandrien Janssens1, Hector Novoa de Armas, Ward D'Autry, Ann Van Schepdael, Guy Van den Mooter.   

Abstract

The good compatibility between Itraconazole and polyvidone-vinylacetate 64 (PVPVA 64) was pointed out previously. However, the dissolution properties of these systems left room for improvement. Therefore polyethylene glycol 6000 (PEG 6000), known for its solubilizing and wetting properties, was added to the PVPVA 64 matrix. Physicochemical analysis showed that up to 10% of PEG 6000 could be mixed with PVPVA 64. Addition of 10%, 20% or 40% of Itraconazole rendered amorphous solid dispersions consisting of a ternary mixed phase and a PVPVA 64 rich amorphous phase. If the PEG 6000 fraction was elevated up to 25% of the carrier, the PEG 6000 crystallinity degree was around 73+/-0.6%. Up to 20% of Itraconazole could be molecularly dispersed in the 25/75 w/w polymer blend. An Itraconazole melting peak could be detected for the sample containing 40% of drug. Dissolution experiments showed that no benefit was obtained by adding PEG 6000 to the PVPVA 64 matrix for samples containing up to 20% of Itraconazole. The dissolution of the ternary dispersions with 40% of Itraconazole on the other hand showed improvement compared to binary Itraconazole/PVPVA 64 dispersions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502629     DOI: 10.1016/j.ejpb.2008.02.007

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

Review 1.  Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.

Authors:  Justin S LaFountaine; James W McGinity; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2015-08-26       Impact factor: 3.246

2.  Screening methodologies for the development of spray-dried amorphous solid dispersions.

Authors:  Íris Duarte; José Luís Santos; João F Pinto; Márcio Temtem
Journal:  Pharm Res       Date:  2014-08-19       Impact factor: 4.200

3.  Improved albendazole dissolution rate in pluronic 188 solid dispersions.

Authors:  Silvina G Castro; Sergio Sanchez Bruni; Carlos E Lanusse; Daniel A Allemandi; Santiago D Palma
Journal:  AAPS PharmSciTech       Date:  2010-10-14       Impact factor: 3.246

4.  Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.

Authors:  Tapan Parikh; Harpreet K Sandhu; Tanaji T Talele; Abu T M Serajuddin
Journal:  Pharm Res       Date:  2016-03-07       Impact factor: 4.200

5.  Preparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.

Authors:  Peng Hou; Jian Ni; Sali Cao; Haimin Lei; Zhengjun Cai; Tao Zhang; Fang Yu; Qingzhong Tan
Journal:  AAPS PharmSciTech       Date:  2013-04-30       Impact factor: 3.246

6.  Material Considerations for Fused-Filament Fabrication of Solid Dosage Forms.

Authors:  Evert Fuenmayor; Martin Forde; Andrew V Healy; Declan M Devine; John G Lyons; Christopher McConville; Ian Major
Journal:  Pharmaceutics       Date:  2018-04-02       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.